Literature DB >> 2461903

Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody.

J A Trapani1, S Mizuno, S H Kang, S Y Yang, B Dupont.   

Abstract

It has previously been shown that a mouse monoclonal antibody, designated 4E, reacts with an epitope common to all HLA-B and -C antigens and those of the HLA-Aw19 cross-reactive group, namely, HLA-A29, -A30, -A31, -A32, -Aw33, and -Aw74. In order to pinpoint the amino acid residues which comprise the public specificity recognized by 4E, and HLA-A29 cDNA clone was isolated and its predicted amino acid sequence compared with those of other cloned HLA class I genes. The isolated HLA-A29 cDNA corresponded to the rarer of the two A29 variant alleles, A29.1. Two amino acid residues of HLA-A29.1, gln-144 and arg-151, were found in all 24 HLA-B and HLA-C alleles examined but were present in only one of 15 HLA-A alleles for which sequence data are available. Importantly, this exceptional allele was HLA-A32, another member of the HLA-Aw19 cross-reactive group. Gln-144 and arg-151 should be capable of jointly contributing to the binding site for 4E, as they are situated in successive alpha-helical subregions and are predicted to be juxtaposed in the three-dimensional HLA molecule. Four other residues in the first or second external domains of HLA-A29.1 (thr-9, leu-62, gln-63, and his-102) were unique among the HLA-A alleles, but none of these was found in corresponding positions of HLA-B of -C alleles and thus failed to correlate with presence or absence of the 4E determinant. These observations are consistent with the notion that gln-144 and arg-151 define a determinant common to HLA-B, HLA-C, and the HLA-Aw19 cross-reactive group and the binding site of the monoclonal antibody 4E.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2461903     DOI: 10.1007/bf02341610

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  40 in total

1.  Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA-A alleles at the nucleotide level.

Authors:  B H Koller; H T Orr
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  The complete primary structure of HLA-Bw58.

Authors:  J P Ways; H L Coppin; P Parham
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

3.  Comparison of the structure of HLA-Bw47 to HLA-B13 and its relationship to 21-hydroxylase deficiency.

Authors:  J Zemmour; P D Ennis; P Parham; B Dupont
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.

Authors:  C F Ware; M S Krangel; D Pious; S J Burakoff; J L Strominger
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

5.  Gene conversion in MHC genes.

Authors:  J Klein
Journal:  Transplantation       Date:  1984-10       Impact factor: 4.939

6.  The major histocompatibility complex in man.

Authors:  J Dausset
Journal:  Science       Date:  1981-09-25       Impact factor: 47.728

7.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

8.  Structural analysis of an HLA-B27 population variant, B27f. Multiple patterns of amino acid changes within a single polypeptide segment generate polymorphism in HLA-B27.

Authors:  S Rojo; P Aparicio; S Y Choo; J A Hansen; J A López de Castro
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

9.  Structural analysis of an HLA-B7 antigen variant detected by cytotoxic T lymphocytes.

Authors:  S Taketani; M S Krangel; H Spits; J de Vries; J L Strominger
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

10.  Complete nucleotide sequence of a functional class I HLA gene, HLA-A3: implications for the evolution of HLA genes.

Authors:  T Strachan; R Sodoyer; M Damotte; B R Jordan
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

View more
  12 in total

1.  Patterns of nucleotide substitutions inferred from the phylogenies of the class I major histocompatibility complex genes.

Authors:  T Imanishi; T Gojobori
Journal:  J Mol Evol       Date:  1992-09       Impact factor: 2.395

2.  Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.

Authors:  John Sidney; Scott Southwood; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-07-08       Impact factor: 2.846

3.  Definition of epitopes on HLA class I molecules by polyclonal antipeptide sera.

Authors:  M Bouillot; J Choppin; J P Levy
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  HLA-A29 subtypes and birdshot chorioretinopathy.

Authors:  L P de Waal; N M Lardy; A R van der Horst; G S Baarsma; A Kijlstra; L Noens; H A Priem
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 5.  NKT cells at the maternal-fetal interface.

Authors:  J E Boyson; I Aktan; D A Barkhuff; A Chant
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

6.  Nomenclature for factors of the HLA system, 1989. The WHO Nomenclature Committee.

Authors: 
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

7.  Motif of HLA-B*3503 peptide ligands.

Authors:  A Steinle; K Falk; O Rötzschke; V Gnau; S Stevanović; G Jung; D J Schendel; H G Rammensee
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

8.  N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells.

Authors:  R Versteeg; C van der Minne; A Plomp; A Sijts; A van Leeuwen; P Schrier
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

9.  The MHC E locus in macaques is polymorphic and is conserved between macaques and humans.

Authors:  J E Boyson; S N McAdam; A Gallimore; T G Golos; X Liu; F M Gotch; A L Hughes; D I Watkins
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization.

Authors:  Ralf M Leonhardt; Parwiz Abrahimi; Susan M Mitchell; Peter Cresswell
Journal:  J Immunol       Date:  2014-02-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.